Pactiv Evergreen Q1 2024 Adj EPS $0.14 Beats $0.08 Estimate, Sales $1.252B Miss $1.283B Estimate
Portfolio Pulse from Benzinga Newsdesk
Pactiv Evergreen (NASDAQ:PTVE) reported Q1 2024 adjusted EPS of $0.14, surpassing the $0.08 estimate, marking a 7.69% increase from last year. However, their sales of $1.252B fell short of the $1.283B estimate, a 12.51% decrease from the previous year.
May 02, 2024 | 8:18 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Pactiv Evergreen's Q1 2024 earnings beat estimates with an adjusted EPS of $0.14, but sales missed expectations at $1.252B.
The positive earnings surprise could provide a short-term boost to PTVE's stock price due to the better-than-expected EPS. However, the miss on sales forecasts and the significant year-over-year decrease in sales could temper investor enthusiasm, leading to a neutral overall impact in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100